Full text is available at the source.
Abstract
GlP-1 receptor agonists provide reliable weight loss and improved glycemic control in obese and diabetic patients.
- These medications may enhance overall metabolic health.
- They are associated with improved cardiovascular outcomes in high-risk populations.
- Glucagon-like peptide 1 receptors stimulate various tissues, including the pancreas and heart.
- The effects of these medications on gastric emptying are particularly relevant for anesthesia professionals.
Simplified